ECTRIMS eLearning

Accessing MS treatment for all: an update into MSIF’s successful WHO Essential Medicines List bid - Scientific Faculty Room
ECTRIMS Learn. Presenters F. 02/14/24; 409605
Faculty / Presenters
Faculty / Presenters
This content is available to all registered users.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

About Us

The European Committee for Treatment and Research in Multiple Sclerosis serves as the world’s largest professional organisation dedicated to the understanding and treatment of MS.
2025 ©
European Committee for Treatment and Research in Multiple Sclerosis
USER TERMS AND CONDITIONS / PRIVACY POLICY
(Amended according to GDPR)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies